Insider Trading February 3, 2026

Virtu Financial Executive Vice President Reports Multiple Stock Transactions Around Year-End Results

Stephen Cavoli records share sales and RSU conversions on Jan 31 and Feb 2, 2026, as Virtu posts stronger-than-expected Q4 2025 results

By Leila Farooq VIRT
Virtu Financial Executive Vice President Reports Multiple Stock Transactions Around Year-End Results
VIRT

Stephen Cavoli, Executive Vice President at Virtu Financial, recorded multiple transactions in late January and early February 2026, including sales of Class A common stock and the conversion of restricted stock units into shares. The filings disclose a total of 38,285 shares sold across two reports and 47,809 shares acquired through RSU conversion, while price per share was not disclosed. The activity coincides with Virtu Financial reporting fourth-quarter 2025 results that outperformed consensus on both adjusted EPS and revenue.

Key Points

  • Stephen Cavoli, Executive Vice President at Virtu Financial, reported share sales on Jan 31 and Feb 2, 2026, totaling 38,285 shares, with per-share prices not disclosed.
  • On the same dates Cavoli received 47,809 shares through conversion of Restricted Stock Units.
  • Virtu Financial’s fourth-quarter 2025 results beat expectations, with adjusted EPS of $1.85 versus $1.19 expected and revenue of $613.45 million, outperforming forecasts by 21.56%.

Stephen Cavoli, who serves as Executive Vice President at Virtu Financial, Inc. (NASDAQ: VIRT), completed a series of reported equity transactions tied to the company’s Class A common stock on January 31 and February 2, 2026, according to regulatory filings.

The filings state that Cavoli sold a combined total of 38,285 shares across two transactions. The public disclosures specify that on January 31 he sold 19,144 shares, and on February 2 he sold an additional 5,263 shares. The price paid per share for these sale transactions was not disclosed in the filings.

In the same pair of filing dates, Cavoli also recorded acquisitions tied to the conversion of Restricted Stock Units. The documents show that a total of 47,809 shares of Class A common stock were received upon conversion of RSUs on January 31 and February 2.


Earnings context

Separately, Virtu Financial reported fourth-quarter 2025 financial results that exceeded analysts’ forecasts. The company posted adjusted earnings per share of $1.85, versus an anticipated $1.19, representing a 55.46% surprise to expectations. Revenue for the quarter came in at $613.45 million, beating forecasts by 21.56%.

These quarterly results and the insider transactions were disclosed in overlapping timeframes. The filings provide numbers on units sold and units converted but do not attach per-share pricing for the sales. Company earnings and revenue figures are among the primary metrics stakeholders typically use to evaluate a firm’s near-term financial performance and operational trends.

Analysts and investors have noted the stronger-than-expected results, which the filings highlight as part of the broader picture market participants will monitor as Virtu Financial’s performance unfolds. The filings themselves, however, limit details about transaction pricing and offer no commentary on Cavoli’s personal rationale for the trades and conversions.

Where filings leave gaps on valuation details, the combination of equity sales and RSU conversions may nevertheless be observed alongside the firm’s reported quarterly strength, but the documents do not draw a direct link between the corporate results and the insider’s actions.

Risks

  • The filings do not disclose sale prices per share, leaving valuation and proceeds from Cavoli’s sales unclear - this limits assessment for investors and market participants.
  • Reported transaction totals contain limited granularity on timing and intent; without commentary, it is uncertain how the insider activity relates to the company’s Q4 2025 results.
  • Potential market interpretation risk exists when insider transactions occur near the release of unexpectedly strong quarterly results, as observers may seek causal links not provided by the filings.

More from Insider Trading

Mirum Pharmaceuticals COO Sells Shares as Company Posts Strong Sales and Raises Guidance Feb 3, 2026 Mirum CEO Sells $941k of Stock as Company Nears 52-Week High Feb 3, 2026 Mirum Pharmaceuticals SVP Sells Shares to Settle RSU Taxes as Company Posts Strong 2025 Sales Feb 3, 2026 908 Devices CFO Disposes $143K in Shares as Company Posts Revenue Gains Feb 3, 2026 908 Devices CEO Sells $214,841 in Stock After Exercising RSUs Feb 3, 2026